Background: IgA nephropathy (IgAN) is characterized by the deposition of the IgA1-IgG immune complex in glomerular mesangial areas. The progression of IgAN in patients is more prominent in men than women. Grouped ddY (gddY) mice are a useful animal model for IgAN patients. However, the mechanisms underlying the gender difference in IgAN has not been clearly understood.
Introduction
IgA nephropathy (IgAN) is a disease characterized by the binding of galactose-deficient IgA1 (GdIgA1) or anti-GdIgA1 IgG autoantibody to produce IgA1/IgG immune-complexes (IgA1/IgG IC) that deposit in the renal glomerular mesangial areas 1)- 3) . It is assumed that an upper respiratory tract infection and/or tonsillar mucosal infection impairs immune tolerance and stimulates B cells (CD19 + B cells) or dendritic cells through TLR9/ MyD88. Mucosal B cells may secrete circulating GdIgA1, which induces renal mesangial IgA deposition and kidney injury 4) -6) . An immunohistological analysis of renal biopsy tissues shows that mesangial cell proliferation and matrix expansion are associated with glomerular immune deposition of IgA1/IgG IC, C3, and/or IgM co-deposits. These . The ddY mouse, a spontaneous animal model of IgAN, was first reported in 1985 11) . Our research group has established that early onset IgAN-prone "grouped ddY"(gddY) mice that will 100%
develop IgAN within 8 weeks of age and has identified four marker loci (D1Mit216, D1Mit16, D9Mit252, and D10Mit86), which linked with the early onset-phenotype in a genome-wide association analyses. This model shows mild proteinuria without hematuria, glomerular IgA and IgG codeposition, with a highly variable incidence and degree of glomerular injury due to the heterogeneous genetic background, and a similarity to human IgAN. Furthermore, it has been reported that renal failure worsens earlier in male mice than female 12) .
Therefore, we hypothesized that gddY mice can be a useful model for the observation of underlying molecular mechanisms of the sex difference on the progression of IgAN. Despite of the conflict effects of breast cancer, the potentially protective effects of estrogen on neuron, bone, cardiovascular tissue, kidney, endocrine organ, liver and immune system were reported. The estrogen activates through the estrogen receptors (Erα, β) and estrogen-related receptors signaling pathways and regulates the splice in the target cells to exhibit inflammatory or anti-inflammatory effect on each organ 13)-15) . It has been reported that E2 also exerts potent anti-oxidative effects that may contribute to a protective effect for the female gender during the course of renal diseases by modulating cell proliferation and the synthesis and degradation of collagen and proteoglycans. In addition, estrogen may indirectly influence these processes by modulating the synthesis and release of vasoactive agents, cytokines, and growth factors, which in turn are capable of altering renal mesangial cells, tubular epithelial cells, and interstitial cell function 16)-18) .
Several experimental studies with glomerulosclerosis-(GS) susceptible mice have indicated that an estrogen deficiency may alter the balance of renal development and contribute to progression of GS. It was reported that ROP mice develop GS during their life span in response to nephron reduction 19) and that ovariectomized female GS-prone ROP mice decreased not only mRNA expressions of Erα and Erβ, but also ER transcriptional activities in glomeruli and mesangial cells (MCs) 20 . These examinations then would partially elucidate the renal protective effects of E2.
Materials and Methods

Experimental model design
The experimental protocol of this study was approved by the Ethics Review Committee for Animal Experimentation of the Juntendo University Faculty of Medicine, Tokyo, Japan. The gddY mice were established through the selective mating of early-onset IgA prone ddY mice for more than 20 generations 12) . This resulted in 100% proteinuria, mesangial cell proliferation, and mesangial matrix expansion with gdIgA1 depositions at 8 weeks. The mice were maintained in specific pathogen free (SPF) room at the animal facility of Juntendo University, Tokyo, Japan.
Fifteen female gddY mice were divided into four groups. The mice of 2 control groups were sacrificed at 4 weeks (4wFC; N = 4) and 14 weeks (14wFC; N = 4) of age. Ovariectomies were performed on seven of the mice ovariectomy at 6 weeks of age and 3 of them were replaced with estrogen pellets until 14 weeks of age, and then sacrificed (14wO + E2; N=3). Another 4 ovariectomized mice without any therapy were sacrificed at 14 weeks of age (14wOvx; N = 4).
Ovariectomy via the dorsal route and replacement of E2
Ovariectomies were performed using inhalational anesthetic with isoflurane (Mylan Pharmaceuticals Co, Ltd. Tokyo, Japan). Dorsal incision 1.5 cm long, between the middle of the back and the base of the tail. Incisions of the muscles were made bilaterally. After the peritoneal cavities were accessed, the ovaries were surrounded by a variable amount of fat. The fat tissue was connected with the kidney capsule. Using an electric knife (V-10, BRC, Tokyo, Japan) to separate the fat tissue, we removed the ovaries. The fallopian tubes and blood vessels were ligated with the electric knife. After ensuring that no bleeding was present, the peritoneal cavity and the dorsal skin incision was closed using three single catgut stitches (Matsuda Sutures Tokyo, Japan).
In the 14wO + E2 group mice, as mentioned above, we implanted an E2 pellet (0.18 mg, 60-day slow release, 3 mm in diameter, SE-121; IRA, Sarasota, FL, USA) into the subcutaneous tissue of the neck after a dorsal incision using small size tweezers. The doses of E2 are frequently used by researchers and have been claimed to establish physiologically safe concentrations of E2 (4.6-21 pg/ml during oestrus to 57-88 pg/ml during pro-oestrus) and exert a beneficial effect in mice 26) .
Serum and urinary analyses
Blood samples were obtained from the buccal vein and centrifuged at 3,000 g at 4℃ for 10 min with the serum stored at -80℃ prior to use. Mice were housed in metabolic cages for 24 h to collect urine. The urine samples were centrifuged at 800 g at 4℃ for 5 minutes and stored at -80℃. These samples were collected at 4 and 14 weeks of age. Serum IgA and IgA-IgG IC were measured using a sandwich ELISA kit (Bethyl Laboratories, Montgomery, TX) using a modified method based on our previous report 6) 12) . Purified rat anti-mouse IgG antisera (BD Biosciences, Pharmingen, San Diego, CA) and horseradish peroxidase-conjugated goat anti-mouse IgA (Zymed Laboratories, San Francisco, CA) were used for immunofluorescence (IF). Serum dihydrotestosterone (sDHT) was measured with a sandwich ELISA kit (Cusabio, Wuhan, China). Albuminuria was defined according to the albumin/creatinine ratio (ACR μg/mg) using a DCA 2000 immunoassay system (Siemens Healthcare Diagnostics, Tokyo, Japan).
Histological analysis
Kidneys were removed after perfusion with normal saline. For light microscopy, specimens obtained from the renal cortex were fixed in 20% formaldehyde and embedded in paraffin, and 3-μm sections were collected. These sections were stained with hematoxylin and eosin (H-E), and periodic acid-Schiff (PAS). For the quantitative analysis of glomerular sclerosis (GS), global glomeruli/crosssections were observed and assigned the following scores based on previous reports 12) 27) , as follows: 0 points, no GS; 1 point, mild GS (approximately 25%); 2 points, moderate GS (approximately ≦50%); and 3 points, severe GS (approximately ≦75%).
The sclerosis scores were calculated as follows:
[Σsevere glomerular sclerosis number of global kidney section/glomerular number global kidney section].
Immunofluorescence (IF) staining
Kidney specimens were mounted in an optimal cutting temperature (OCT) compound (Sakura Finetek, Tokyo, Japan) and then stored at -80℃. The specimens were cut into 3-μm sections and fixed with acetone at -20℃ for 5 min. A DyLight 594-conjugated goat anti-mouse IgA antibody (ab, 13442, Abcam, Tokyo, Japan), Alexa 488-conjugated goat anti-mouse IgG antibody (Invitrogen AG, Basel, Switzerland), and FITC-conjugated rat monoclonal anti-mouse C3 antibody (11H9 sc-58926 Santa Cruz, California, USA) were used for these IF staining 6) 12) . After overnight an incubation Kelimu, et al: Estrogen effects on murine IgA nephropathy at 4℃ and a washing with PBS 3 times, the slides were mounted with a mounting medium (Dako, Tokyo, Japan). These samples were imaged using confocal laser microscopy (Olympus Corporation, Tokyo, Japan).
Immunohistochemistry
The kidney sections for the immunohistochemistry of F4/80 were fixed with acetone at -20℃ for 5 min. After blocking with 0.3% H2O2 in 70% methanol/PBS at room temperature (RT) for 30 min, they were incubated with a rat monoclonal anti-mouse F4/80 antibody (CI: A3-1 ab6640 Abcam, Tokyo, Japan) at 4℃ overnight. After washing with PBS 3 times, the slides were incubated with an HRP-conjugated rabbit anti-rat IgG antibody (Dako, Tokyo, Japan) at RT for 30 min. After washing three times with PBS and once with water, the slides were incubated with a DAB substrate solution (Dako, Campintenia, USA) for 5 min, which resulted in a brown staining. After counterstaining with hematoxylin for 5 min and washing with water, we finally mounted them with a mounting medium (Dako, Tokyo, Japan). The sections were observed with a light microscope (Olympus Corporation, Tokyo, Japan). The numbers of F4/80 positive cells were counted in the kidney sections of each mouse at each time point.
Real-time polymerase chain reaction (PCR)
assays Total RNA was extracted from the cortex of kidneys with the TRIzol reagent (Invitrogen AG, Basel, Switzerland) and RNeasy mini kit (Qiagen).
PCR was performed using a Fast SYBR Green master mix (Applied Biosystems) and a 7, 500 real-time PCR system (Applied Biosystems). The results were quantified using a standard curve generated from the analysis of serial dilutions of a reference cDNA prepared from the kidneys from other gddY mice, and data were normalized to those of GAPDH mRNA. We performed a quantitative real-time PCR to determine the levels of GAPDH, Erα, Erβ, and TGF-β1 mRNAs using the primers (Invitrogen, California, USA) shown in Table- 1.
Statistical analysis
The correlation between different parameters was analyzed using an analysis of variance. Data are expressed as the mean±standard deviation. p values of <0.05 were considered statistically significant. All statistical analyses were performed using SPSS 20 software (IBM Corporation, Armonk, NY, USA). A paired t-test was used for a comparison of the mean scores between the 14wFC and the other 3 groups, respectively.
Results
Estrogen depletion increased pathological severity, including the amount of IgA deposition, and was reversed by E2 replacement
The levels of urinary ACR and serum concentration of IgA were significantly increased in all mice with ageing and higher in 14wOvx groups than 14wFC. The rise of them were reversed in E2 replacement mice group compared with ovariectomy mice as shown in Table- were observed in serum concentration of IgA-IgG IC. The histologic changes in the glomeruli, such as mesangial cell proliferation and mesangial matrix expansion, were observed in 14w of age and estrogen depletion by Ovx increased in the degree of severity, while the replacement of E2 showed a recovery of about half (Figure-1A, B) . Increased glomerular deposits of IgG, IgA, and C3 were also observed coincident with renal histopathologic damage appearance, as shown in Figure-1C . 
E2 replacement therapy restored sDHT
The concentration of sDHT was increased in 14wOvx and was reversed in 14wO + E2 to the level of 14wFC. The result indicates that the E2 replacement by E2 pellets restored E2 levels after ovariectomy (Figure-2 ).
Interstitial macrophage infiltration
Interstitial infiltrations of F4/80 positive cells, i.e. macrophages, are shown in Figure-3 . By immunohistochemistry, F4/80 positive macrophages were diffusely observed in the interstitium in 14wOvx. The increased F4/80 positive macrophages in 14wOvx were markedly reduced by E2 replacement (14wO + E2) to the levels of 14wFC. These results suggest that E2 may play a protective role by decreasing sDHT and inhibiting macrophage infiltration.
Ovariectomy (Ovx) increased Erα and TGF-β1
mRNA expression Erα and TGF-β1 mRNA were increased by Ovx and reversed by E2 replacement (Figures-4A, C) . However, Erβ was not changed by Ovx but increased by E2 replacement (Figure-4B ).
Discussion
The objective of this study was to examine the pathological roles of estrogen in murine IgA nephropathy (IgAN) and elucidate its underlying mechanisms, since a gender difference is one of the key factors in the prognosis of this disease. Since it has been postulated that female sex hormones have renal protective effects in mice with severe glomerulosclerosis (GS) 16 )- 18) , we divided female gddY mice, i.e. animal model mice for human IgAN, into 3 groups, (1) 14w-old control mice (14wFC), (2) ovariectomized at 6w-old (14wOvx) mice, and (3) E2 replacement after the ovariectomy at 6w-old (14wO + E2) mice and compared the histological changes in their kidneys. As a result, the ovariectomy worsened not only ACR but also GS with immunohistological changes and interstitial macrophage infiltrations, consistent with urinary ACR and, serum IgA and IgA-IgG IC concentrations, although statistically significant difference was not recognized the ACR between 14wOvx and 14wO + E2 because of a limited number of mice. Furthermore, E2 replacement recovered some of these, indicating that the estrogen has protective effects on GS in gddY mice. Therefore, it may suggest that an estrogen deficiency contributes to A: Erα mRNA was increased in 14wOvx mice and replaced in 14wO + E2 mice. B: Erβ mRNA expression was not changed in 14wOvx mice but increased in 14wO + E2 mice. C: TGF-β1 mRNA was increased in 14wOvx mice and recovered to the levels of 14wFC mice in 14wO + E2 mice. . Thus, these results seemed to be correlated with sDHT and with renal histopathological changes, including F4/80 positive cell infiltration.
Recently, it has been proposed that IgAN may be an autoimmune disease in which the B-cells are aberrantly activated by innate-immune systems and thus secrete nephritogenic IgA and related autoantibodies, which leads to glomerular deposition and subsequent kidney injury 4) -6) . On the other hand, it has been long believed that E2 is not only a sex hormone but also an important regulator of the immune system. E2 exerts its effect through two nuclear receptors, i.e. ERα and ERβ, with cooperative-interaction on B-cell maturation and activation playing pro-inflammatory and anti-inflammatory roles in each organ 13)-15) . In this study, we found that mRNA expressions of Erα and Erβ were decreased in 14wFC compared with 4wFC. Interestingly, Erα increased by ovariectomy was restored to previous levels by E2 replacement. However, Erβ did not change through ovariectomy but increased after E2 replacement. We could not explain the difference at this time, although, Erβ exhibits an inhibitory action on Erα-mediated gene expression and in many instances opposes the actions of Erα 15) .
It has been reported that estrogen alters B-cell development to decrease lymphopoiesis and increase the frequency of B-cells appearance in marginal zone. Both Erα and Erβ are required for complete down-regulation of B lymphopoiesis, while only Erα is needed to up-regulate immunoglobulin production in both the bone marrow and spleen 28) 29) . Therefore, it might be a specific change in gddY mice, suggesting abnormalities in their B-cell function.
Since it have reported that the Erα was activated by testosterone and DHT 30) , not only deficiency of estrogen and progesterone but high DHT may induce high Erα expression 30)-32) that contribute the secretion of IgA1 by B-cells. In this study, we measured the mRNA expressions of TGF-β1 mRNA, which was slightly increased by ovariectomy and recovered by E2 replacement. These results support the idea that TGF-β1 plays a central role in promoting progressive kidney injury 15) 22) 23) , and estrogen negatively regulates TGF-β1, contributing to renoprotective effects 17) 18) .
In conclusion, an estrogen deficiency by ovariectomy accelerates the progression of the glomerular injury, further suggesting a contribution of gender difference in IgAN. Macrophage infiltration and TGF-β1 may be involved in the process. Since the physiological level of E2 replacement was not enough to prevent the progression of the glomerulosclerosis (GS), other protective factors aside from E2 lost by ovariectomy, may be involved in the gender difference of gddY mice. These mice may provide useful insights into the pathogenesis of IgAN, such as effect of gender differences on the progression of human IgAN.
